Adherence to Long-Term Therapies - Evidence for Action
(2003; 211 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentAcknowledgements
View the documentScientific writers
View the documentIntroduction
View the documentTake-home messages
Open this folder and view contentsSection I - Setting the scene
Open this folder and view contentsSection II - Improving adherence rates: guidance for countries
Open this folder and view contentsSection III - Disease-Specific Reviews
Close this folderAnnexes
Open this folder and view contentsAnnex I - Behavioural mechanisms explaining adherence
Close this folderAnnex II - Statements by stakeholders
View the document1. Family, community and patients' organizations
View the document2. Behavioural medicine
View the document3. General practitioners/family physicians
View the document4. Industry
View the document5. Nurses
View the document6. Pharmacists
View the document7. Psychologists
View the documentAnnex III - Table of reported factors by condition and dimension
View the documentAnnex IV - Table of reported interventions by condition and dimension
Open this folder and view contentsAnnex V - Global Adherence Interdisciplinary Network (GAIN)
Open this folder and view contentsWhere to find a copy of this book
 

Annex II - Statements by stakeholders

All statements expressed here are the sole responsibility of each individual or organization. None of these statements reflects the views of the World Health Organization on the topic discussed, or those of any other person or organization mentioned in this report.

The stakeholders are listed in alphabetical order, with the exception of patients, who should always come first.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014